New-Born Screening Market Players, Size, Share, Trends, Opportunities, Growth Analysis and Forecast to 2032
Newborn
screening is the practice of testing every newborn for some harmful or possibly
fatal disorders that are not otherwise obvious at birth. New-born screening
involves the use of various devices for the screening procedure. Diseases such
as phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell
disease, cystic fibrosis, tyrosinemia, and other such disorders can be screened
using new-born screening devices. The rising prevalence of neonatal conditions
and government support along with new-born screening programs have led to the
growth of the new-born screening market in recent years. Additionally,
increasing neonatal population and technological advancements are likely to
contribute to the growth of the market over the assessment period.
The new-born screening market is projected to reach USD 1.02 Billion by 2032 at 8.20% CAGR during the forecast
period 2023-2032
The key factors
driving the market growth are increasing spending by government organizations
on healthcare, rising prevalence of diseases in new-born children, and
increasing neonatal population. However, factors such as the unreliability of
new-born screening tests and lack of proper healthcare infrastructure and
trained professionals may hamper the market growth
Major Key
Players:
MRFR recognizes the New-Born Screening Market Players are —SCIEX (US), PerkinElmer
Inc. (US), WATERS (US), Natus Medical Incorporated (US), Masimo Corporation
(US), Agilent Technologies Inc. (US), Bio-Rad Laboratories, Inc. (US),
Medtronic (Ireland), GENERAL ELECTRIC (Boston), Trivitron Healthcare (India),
and ZenTech SA (Belgium)
Segment Analysis
The global new-born screening market is segmented
into product, technology, test type, and end-user
The global new-born screening market by-products has been
bifurcated into instruments and reagents and assay kits. By technology,
the new-born screening market has been divided into newborn metabolic screening,
DNA
assays, electrophoresis, pulse oximetry, immunoassays, and enzymatic
assays, and hearing screening technology. Based on the test type, it has been
segregated into dry blood spot tests, critical congenital heart disease (CCHD)
tests, urine
tests, and hearing screening tests. The global new-born screening
market, by end-user, has been classified as hospitals, maternity and specialty
clinics, diagnostic centers, and others.
Regional
Analysis
The global new-born
screening market, based on region, has been divided into the Americas,
Europe, Asia-Pacific, and the Middle East & Africa.
The Americas are anticipated to
hold a significant share in the global new-born screening market. According to
data published by the Centers for Disease Control and Prevention (CDC) in
November 2018, congenital heart defects (CHD) affect approximately 1% or about
40,000 births per year in the US. Also, increasing awareness and rising demand
for new-born screening are expected to drive market growth.
The new-born screening market in
Europe is expected to propel owing to factors such as the rising prevalence of
neonatal disorders and raising awareness about these disorders and their
screening programs. According to a report published by the European Medicines
Agency in May 2015, 1 in 10,000 babies born in the European Union was affected
by perinatal asphyxia (a neonatal disorder wherein babies are born without
enough oxygen in the blood). Also, technological advancements in the industry
and government support in terms of National Health Service and health insurance
are expected to drive market growth.
Asia-Pacific is anticipated to be
the fastest-growing region in the global new-born screening market owing to the
rising neonatal population, increasing mortality rate of neonates, and
improving healthcare infrastructure. According to data published by the United
Nation’s International Children’s Emergency Fund (UNICEF), the rate of neonatal
mortality in India was 24% in 2017. According to a report published by the
National Center for Biotechnology Information (NCBI) in December 2016,
approximately 0.75 million neonates die in India every year. The neonatal
mortality rate (NMR) for India is the highest for any country in the world.
Also, the rising prevalence of neonatal disorders in developing countries and
government support is fueling the growth in the market.
The new-born screening market in
the Middle East & Africa is expected to significantly grow owing to the
developing healthcare infrastructure and government support. The American
Society of Hematology (ASH), led a campaign to fight the sickle cell disease in
Africa in June 2018. It also urged the governments, particularly in Sub-Saharan
Africa, to invest in new-born screening of the disease. Additionally, raising
awareness of newborn screening is fueling the growth in the market.
About Market Research
Future
At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market Research & Consulting
Services.
MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions.
In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members.
Contact us:
Market Research Future
(part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Comments
Post a Comment